tirzepatide contraception and Plan B: What to Know About Emergency Reta and Tirzepatide reduce the

A large retrospective cohort study suggested GLP1 receptor agonist use was not associated with a substantially increased risk (1.33 events per 10,000 person years) of thyroid cancer over a mean follow-up of 3.9 years [56]

Contraindicaciones: Historia personal o familiar de carcinoma medular de tiroides Neoplasia endocrina mltiple tipo 2 (MEN 2) Reacciones de hipersensibilidad graves al medicamento Advertencias y precauciones importantes: Pancreatitis: Existe un riesgo bajo pero importante de pancreatitis aguda

The article states that the plateau typically arriving after month six to eight is physiologic, reflecting metabolic adaptation, and does not indicate treatment failure

Journal of Molecular Medicine , 97(4):473485